missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Beclin-1 Polyclonal Antibody, Invitrogen™

Beclin-1 Antibody, PA1-18287, from Invitrogen™. Species Reactivity: Human; Applications: Immunofluorescence, Immunohistochemistry.

Manufacturer:  Pierce Biotechnology Inc PA118287

Catalog No. 01-670-540


 

Specifications

Description

Beclin-1 Antibody, PA1-18287, from Invitrogen. Species Reactivity: Human; Applications: Immunofluorescence, Immunohistochemistry.

Beclin-1 may play a role in antiviral host defense, as it protects against infection by a neurovirulent strain of Sindbis virus. Also, Beclin-1 may play a role in autophagy.
Host Species: Rabbit
Cross Reactivity: Human
Isotype: IgG
Immunogen: Synthetic peptide corresponding to the C-terminal residues of human Beclin-1.
Formulation: 100μL unpurified antibody in whole serum and no preservative
Synonyms: BECN1, APG6, Coiled-coil myosin-like BCL2-interacting protein, Protein GT197
Uniprot Accession: Q14457
Entrez GeneID: 8678
Gene Symbol: BECN1
PA1-18287 detects Beclin-1 from human samples. PA1-18287 has been successfully used in immunohistochemistry and immunofluorescence procedures. The PA1-18287 immunogen is a synthetic peptide corresponding to the C-terminal residues of human Beclin-1, conjugated to Blue Carrier Protein. The sequence is 100% conserved in mouse and rat. Reconstitute with 100 ul of distilled water.
Description & Specifications

Specifications

Beclin-1
Unlabeled
Q14457
BECN1, APG6, Coiled-coil myosin-like BCL2-interacting protein, Protein GT197
Rabbit
IgG
Avoid Freeze/Thaw Cycles
Polyclonal
Human
Immunofluorescence,Immunohistochemistry
100μL unpurified antibody in whole serum and no preservative
Serum
BECN1
Synthetic peptide corresponding to the C-terminal residues of human Beclin-1.
100μL
Primary
8678
Promotions

Promotions

  • Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.

    06/30/18